They messed up the entire region, she said. She called Metabiota’s attempt to claim credit for its Ebola work an insult for the memories of thousands of Africans who have died.

U.S. health official Austin Demby, who evaluated Metabiota’s and Tulane’s lab work at the request of the U.S. Centers for Disease Control and Prevention and the government of Sierra Leone, was also critical.

In one email, Demby noted used needles were left out and there was no ultraviolet light for decontamination. The space was also too small to safely process blood samples. “The cross-contamination potential is huge and quite frankly unacceptable,” he wrote.

Anja Wolz, an emergency coordinator with Doctors Without Borders, told AP she witnessed Metabiota workers entering homes of suspected Ebola patients without protective gear, and leaving high-risk areas without performing any kind of decontamination procedure.

Metabiota investors include In-Q-Tel, a CIA venture capital firm that specializes in high-tech investments that support or benefit the intelligence capacity of U.S. intelligence agencies, Hunter Biden’s investment fund, Rosemont Seneca and the U.S. Department of Defense’s Threat Reduction Agency (DTRA), which contracted Metabiota to run operations in U.S.-connected labs in Ukraine.

In addition to having close ties to the WEF and its Great Reset agenda, Nathan Wolfe, the founder of Metabiota, has also served on the EcoHealth Alliance’s editorial board since 2004. In 2017, he co-wrote a study on coronaviruses in bats together with EcoHealth president Peter Daszak, Ph.D. EcoHealth worked closely with the Wuhan Institute of Virology (WIV) in China, where SARS-CoV-2 is suspected of having originated.

Metabiota’s Global Partnerships are led by Andrew C. Weber, former assistant secretary of defense for Nuclear, Chemical and Biological Defense, who created the DTRA.